News
Truist Securities Maintains Buy on Compugen, Raises Price Target to $5
8 Mar 24
News, Price Target, Analyst Ratings
Compugen Q4 EPS $0.11 Misses $0.23 Estimate, Sales $33.46M Beat $20.00M Estimate
5 Mar 24
Earnings, News
Earnings Scheduled For March 5, 2024
5 Mar 24
Earnings
Earnings Preview For Compugen
4 Mar 24
Earnings
Press releases
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024
6 May 24
Press Releases
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024
25 Apr 24
Press Releases
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
10 Apr 24
Press Releases
Compugen to Participate in Two Upcoming Investor Conferences
3 Apr 24
Press Releases
Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy
11 Mar 24
Press Releases
Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024
6 Mar 24
Press Releases
Compugen Reports Fourth Quarter and Full Year 2023 Results
5 Mar 24
Earnings, Press Releases
Thinking about buying stock in Volcon, Abeona Therapeutics, Agenus, Viking Therapeutics, or Compugen?
29 Feb 24
Opinion, Press Releases
Compugen to Present at the Leerink Partners Global Biopharma Conference 2024
26 Feb 24
Press Releases
Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer
15 Feb 24
Press Releases